Roche Sponsored Session: Procalcitonin: Aiding Clinician Decision- Making In Infectious Illness

Session Description: 

Sepsis may arise in a variety of different patient populations presenting with other confounding diseases such as pneumonia or COVID-19. Procalcitonin (PCT) is both a sensitive and specific biomarker that can assist in the identification of bacterial infections enabling rapid diagnosis and treatment of sepsis. Dr. Sean X. Neath examines the role that PCT can play in differentiating viral and bacterial infections, antibiotic stewardship, and the value in using with patients presenting with dyspnea or even COVID-19. At the end of the presentation, the learner will be able to articulate the value that PCT brings to clinical practice and understand various use cases for clinical application of the biomarker.

This session was originally presented in September 2021 as part of the 2021 Sepsis Alliance Summit.

Target Audience

Nurses, Advanced Practice Providers, Physicians, Emergency Responders, Pharmacists, Medical Technologists, Respiratory Therapists, Physical/ Occupational Therapist, Social Workers, Mental Health Professionals, Students, IT Professionals, Sepsis Survivors, Advocates, and more! 

 

Sepsis Alliance gratefully acknowledges the support provided for this session by Roche.

Course summary
Course opens: 
06/15/2019
Course expires: 
12/31/2024

Sean-Xavier Neath, MD, PhD

Associate Professor of Clinical Emergency Medicine, University of California, San Diego

Dr. Neath earned his Ph.D. and M.D. degrees from the University of Chicago. He completed his internship at Mercy Hospital in San Diego and his residency in Emergency Medicine at the University of California, San Diego. Dr. Neath joined the faculty of the University of California San Diego in 2001. His research interests include the application of novel biomarkers in the diagnosis and management of acute medical conditions such as sepsis, heart disease, allergy and immunology. Dr. Neath served as one of the co-principal investigators at the UCSD site for the BACH (Biomarkers in Acute Heart Failure) trial, the largest natriuretic peptide acute failure study to date. He is a fellow of the American College of Emergency Physicians and a member of American Heart Association. Dr. Neath is a recipient of the Society for Academic Emergency Medicine Award, and the Wayne C. Booth Prize for Excellence in Graduate Teaching from the University of Chicago. Sean was awarded the American Red Cross “Real Heroes” award for humanitarian disaster relief work in Haiti after the earthquake of January 2010. 

No continuing education credits are offered for this session.

Medical Disclaimer

The information on or available through this site is intended for educational purposes only. Sepsis Alliance does not represent or guarantee that information on or available through this site is applicable to any specific patient’s care or treatment. The educational content on or available through this site does not constitute medical advice from a physician and is not to be used as a substitute for treatment or advice from a practicing physician or other healthcare provider. Sepsis Alliance recommends users consult their physician or healthcare provider regarding any questions about whether the information on or available through this site might apply to their individual treatment or care.

Please login or register to take this course.

 

This activity includes:

  • Slides to download
  • Pre-recorded presentation